NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,917,514 | -15.3% | 18,825 | -16.0% | 0.45% | +3.4% |
Q2 2023 | $2,262,806 | -20.5% | 22,424 | -27.5% | 0.44% | -7.4% |
Q1 2023 | $2,847,308 | +104235.2% | 30,949 | +2.9% | 0.47% | +1.5% |
Q4 2022 | $2,729 | -99.9% | 30,084 | -5.3% | 0.46% | +8.4% |
Q3 2022 | $2,414,000 | -19.2% | 31,759 | -10.1% | 0.43% | -12.0% |
Q2 2022 | $2,988,000 | -4.1% | 35,343 | -0.5% | 0.48% | +14.7% |
Q1 2022 | $3,117,000 | -8.5% | 35,522 | -8.8% | 0.42% | +1.2% |
Q4 2021 | $3,408,000 | +3.5% | 38,965 | -3.2% | 0.42% | -6.9% |
Q3 2021 | $3,292,000 | -14.4% | 40,256 | -4.5% | 0.45% | -12.3% |
Q2 2021 | $3,845,000 | +4.7% | 42,141 | -1.9% | 0.51% | -0.4% |
Q1 2021 | $3,672,000 | -10.5% | 42,952 | -1.1% | 0.51% | -16.4% |
Q4 2020 | $4,103,000 | +4.4% | 43,451 | -3.9% | 0.62% | -6.0% |
Q3 2020 | $3,931,000 | -2.7% | 45,201 | -2.3% | 0.65% | -8.9% |
Q2 2020 | $4,040,000 | +1.8% | 46,258 | -3.9% | 0.72% | -14.0% |
Q1 2020 | $3,968,000 | -17.5% | 48,123 | -5.2% | 0.84% | +6.5% |
Q4 2019 | $4,807,000 | +7.2% | 50,768 | -1.6% | 0.78% | +1.0% |
Q3 2019 | $4,483,000 | -13.3% | 51,593 | -8.9% | 0.78% | -11.8% |
Q2 2019 | $5,170,000 | -7.7% | 56,618 | -2.8% | 0.88% | -11.7% |
Q1 2019 | $5,600,000 | +9.6% | 58,253 | -2.2% | 1.00% | +0.5% |
Q4 2018 | $5,110,000 | -5.8% | 59,553 | -5.4% | 0.99% | +16.2% |
Q3 2018 | $5,424,000 | +10.6% | 62,949 | -3.0% | 0.85% | +7.8% |
Q2 2018 | $4,904,000 | -12.7% | 64,925 | -6.5% | 0.79% | -17.5% |
Q1 2018 | $5,616,000 | -10.3% | 69,465 | -6.9% | 0.96% | -3.6% |
Q4 2017 | $6,263,000 | -5.7% | 74,595 | -3.6% | 1.00% | -6.9% |
Q3 2017 | $6,642,000 | -7.6% | 77,371 | -10.2% | 1.07% | -7.8% |
Q2 2017 | $7,190,000 | +9.0% | 86,135 | -3.0% | 1.16% | +7.9% |
Q1 2017 | $6,597,000 | -10.1% | 88,819 | -11.9% | 1.08% | -12.2% |
Q4 2016 | $7,342,000 | -9.9% | 100,802 | -2.3% | 1.22% | -10.2% |
Q3 2016 | $8,146,000 | -2.7% | 103,172 | +1.7% | 1.36% | -7.3% |
Q2 2016 | $8,370,000 | +31.3% | 101,447 | +15.2% | 1.47% | +27.3% |
Q1 2016 | $6,377,000 | -16.5% | 88,026 | -0.9% | 1.16% | -16.5% |
Q4 2015 | $7,641,000 | +16.5% | 88,802 | +24.5% | 1.38% | +12.9% |
Q3 2015 | $6,559,000 | -9.0% | 71,355 | -2.6% | 1.23% | +1.3% |
Q2 2015 | $7,204,000 | -2.3% | 73,255 | -2.0% | 1.21% | +0.7% |
Q1 2015 | $7,372,000 | +1.3% | 74,762 | -4.8% | 1.20% | +4.0% |
Q4 2014 | $7,278,000 | -2.4% | 78,545 | -0.8% | 1.16% | -3.2% |
Q3 2014 | $7,455,000 | +3.4% | 79,195 | -0.5% | 1.19% | +2.9% |
Q2 2014 | $7,207,000 | +4.9% | 79,609 | -1.5% | 1.16% | +0.2% |
Q1 2014 | $6,870,000 | +6.4% | 80,805 | +0.6% | 1.16% | +4.1% |
Q4 2013 | $6,455,000 | +5.1% | 80,310 | +0.3% | 1.11% | -5.5% |
Q3 2013 | $6,141,000 | +9.6% | 80,056 | +1.0% | 1.18% | +10.1% |
Q2 2013 | $5,602,000 | – | 79,229 | – | 1.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |